Key facts
- It has raised $1.6M; the latest was Early Stage VC in Dec 2025.
- Notable investors include ZhenFund, Jolmo Investment, Hoshi Capital, Kaitai Capital, Panlin Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Levinthal
- ·The full record, as it builds
Funding rounds
No funding rounds for Levinthal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Levinthal
Provider of technical service based on AI-driven protein design intended to drive better industrial production of biological molecules and microbes. The company develops artificial intelligence algorithms and wet experimental process technology, enabling enterprises in the fields of synthetic biology, food, feed, cosmetics and environmental protection to design more stable and more efficient enzymes of various types.
- Sector
- Business Products and Services (B2B)
- HQ
- Hangzhou, China
- Founded
- 2021
- Website
- levinthal.bio/
- Ownership
- Privately Held (backing)
Levinthal doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Levinthal shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Levinthal in its N-PORT filings yet. We sweep new filings monthly.